What is anakinra?
Anakinra (Kineret) is a synthetic (man-made), injectable, interleukin-1 (IL-1) receptor antagonist that blocks the effects of human interleukin-1. It is used in the treatment of rheumatoid arthritis.
- Rheumatoid Arthritis Slideshow Pictures
- Take the RA Quiz
- Joint-Friendly Exercises to Reduce RA Pain Slideshow
- What is anakinra?
- Is anakinra available as a generic drug?
- Do I need a prescription for anakinra?
- Why is anakinra prescribed to patients?
- What are the side effects of anakinra?
- What is the dosage for anakinra?
- Which drugs or supplements interact with anakinra?
- Is anakinra safe to use during pregnancy or while breastfeeding?
- What else should I know about anakinra?
Why is anakinra prescribed to patients?
Anakinra is used for treating the signs and symptoms of moderate to severe rheumatoid arthritis in individuals 18 years of age or older. It is not a first-line drug but is used in individuals who have failed at least one of the other disease-modifying drugs that are used to treat rheumatoid arthritis. It can be used alone or in combination with other agents, but it should not be used with drugs that block tumor necrosis factor alpha such as infliximab (Enbrel) and etanercept (Remicade). (See drug interactions.)
Anakinra also is for used for treatment of neonatal-onset multisystem inflammatory disease (NOMID) due to cryopyrin-associated periodic syndromes (CAPS).
What are the side effects of anakinra?
The most common side effects are reactions at the site of injection, for example, redness, swelling and pain.
Other minor side effects include:
The most serious side effects are an increase in infections and a decrease in the number of white blood cells (neutropenia) and platelets.
Anakinra should not be started in individuals with active infections.
Infections occur more frequently when anakinra is used in combination with drugs that block tumor necrosis factor.
What is the dosage for anakinra?
- The dose of anakinra for rheumatoid arthritis is one subcutaneous injection of 100 mg daily. The dose should be administered at approximately the same time every day.
- The dose for treating neonatal-onset multisystem inflammatory disease (NOMID) is 1-2 mg/kg daily up to a maximum dose of 8 mg/kg.
Which drugs or supplements interact with anakinra?
Anakinra should not be combined with drugs that block tumor necrosis factor (TNF) alpha. Combining anakinra with drugs that block tumor necrosis factor such as infliximab (Enbrel) and etanercept (Remicade) or other drugs that reduce function of the immune system increases the risk of serious infections.
Is anakinra safe to use during pregnancy or while breastfeeding?
Anakinra has not been studied in pregnant women.
It is not known if anakinra is excreted in the breast milk of females who are nursing.
Rheumatoid Arthritis Resources
What else should I know about anakinra?
What preparations of anakinra are available?
Pre-filled syringes, 100 mg
How should I keep anakinra stored?
Anakinra should be kept refrigerated at 2 C to 8 C (36 F to 46 F)
How does anakinra work?
Anakinra blocks the effects of human interleukin-1, and is used in the treatment of rheumatoid arthritis. IL-1 is a protein that is produced by many cells in the body. It is found in increased amounts within joints that are inflamed by arthritis. IL-1 attaches to receptors on the tissues within and surrounding the joints as well as on the cells that are responsible for inflammation, for example, white blood cells. The attachment of IL-1 activates the cells to release enzymes that promote inflammation. The enzymes destroy the cartilage and bone and contribute to pain and swelling of the joints. Anakinra attaches to the IL-1 receptor and prevents IL-1 from attaching to the receptor. Thus, the inflammatory and enzyme-releasing effects of IL-1 are prevented and pain and swelling of the joints are reduced.
When was anakinra approved by the FDA?
Anakinra was approved by the Food and Drug Administration in November 2001.
anakinra (Kineret) is a medication prescribed for the treatment of rheumatoid arthritis in individuals 18 years of age or older, and neonatal-onset multisystem inflammatory disease (NOMID) due to cryopyrin-associated periodic syndromes (CAPS). Side effects, drug interactions, dosage, and pregnancy safety information should be reviewed prior to taking this medication.
Multimedia: Slideshows, Images & Quizzes
Rheumatoid Arthritis Quiz: What is Rheumatoid Arthritis?
How is rheumatoid arthritis different from other forms of arthritis, such as osteoarthritis and gout? Take the Rheumatoid...
Rheumatoid Arthritis (RA) Symptoms & Treatment
What is rheumatoid arthritis (RA)? Learn about juvenile rheumatoid arthritis. Discover rheumatoid arthritis (RA) symptoms,...
Rheumatoid Arthritis (RA) Exercises Slideshow: Joint-Friendly Fitness Routines
Regular exercise boosts fitness and helps reverse joint stiffness for people with rheumatoid arthritis (RA). Our experts offer...
Related Disease Conditions
Juvenile Idiopathic Arthritis (Juvenile Rheumatoid Arthritis)
Juvenile idiopathic arthritis (juvenile rheumatoid arthritis or JRA) annually affects one child in every thousand. There are six...
Rheumatoid Arthritis (RA)
Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints, the tissue around the joints,...
Still's disease (systemic-onset juvenile rheumatoid arthritis) is a disorder characterized by inflammation with high fever...
Treatment & Diagnosis
- Rheumatoid Arthritis FAQs
- Medication Disposal
- Dangers of Mixing Medications
- Drugs: Buying Prescription Drugs Online Safely
- Drugs: The Most Common Medication Errors
- How To Reduce Your Medication Costs
- Pharmacy Visit, How To Get The Most Out of Your Visit
- Indications for Drugs: Approved vs. Non-approved
- Generic Drugs, Are They as Good as Brand-Names?
Medications & Supplements
Prevention & Wellness
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.